Option Fund

Prof. Spyros Artavanis-Tsakonas

Chairman

Department of Cell Biology, Harvard Medical School, Boston, USA

Prof. Joan S. Brugge

Chair of Department of Cell Biology, Harvard Medical School, Boston, USA

Prof. Dr. Daniel Louvard

Director of the Research, Institut Curie, Paris, France

Prof. Hidde Ploegh

Professor of Biology, Massachusetts Institute of Technology.
Member, Whitehead Institute for Biomedical Research

In addition the following people are supporting
the Novartis Option Fund Board:

Anthony Rosenberg

Global Head of BD&L, Novartis Pharma

Dr. Charles Wilson

Global Head of Strategic Alliance, NIBR

Dr. Reinhard Ambros

Head of Novartis Venture Funds